Found: 12
Select item for more details and to access through your institution.
To b(ortezomib) or not to be: the stroma's the thing.
- Published in:
- Journal of Pathology, 2016, v. 240, n. 2, p. 123, doi. 10.1002/path.4763
- By:
- Publication type:
- Article
Molecular markers of serine protease evolution.
- Published in:
- EMBO Journal, 2001, v. 20, n. 12, p. 3036, doi. 10.1093/emboj/20.12.3036
- By:
- Publication type:
- Article
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Csf3r mutations in mice confer a strong clonal HSC advantage via activation of Stat5.
- Published in:
- Journal of Clinical Investigation, 2008, v. 118, n. 3, p. 946
- By:
- Publication type:
- Article
Incidence and impact of community respiratory viral infections in post‐transplant cyclophosphamide‐based graft‐versus‐host disease prophylaxis and haploidentical stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 194, n. 1, p. 145, doi. 10.1111/bjh.17563
- By:
- Publication type:
- Article
Mechanisms and clinical applications of chromosomal instability in lymphoid malignancy.
- Published in:
- British Journal of Haematology, 2015, v. 171, n. 1, p. 13, doi. 10.1111/bjh.13507
- By:
- Publication type:
- Article
Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 449, doi. 10.1002/ajh.26809
- By:
- Publication type:
- Article
Conserved water molecules in the specificity pocket of serine proteases and the molecular mechanism of Na<sup>+</sup> binding.
- Published in:
- Proteins, 1998, v. 30, n. 1, p. 34, doi. 10.1002/(SICI)1097-0134(19980101)30:1<34::AID-PROT3>3.0.CO;2-K
- By:
- Publication type:
- Article
Performance status, comorbidities, and cycles of methotrexate exert the greatest influence on outcomes of primary and secondary CNS lymphomas: the Lexington experience.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 1, p. 141, doi. 10.1007/s00277-022-05018-z
- By:
- Publication type:
- Article
Impact of bortezomib‐based versus lenalidomide maintenance therapy on outcomes of patients with high‐risk multiple myeloma.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2179, doi. 10.1002/cncr.34778
- By:
- Publication type:
- Article
Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 23, p. 5077, doi. 10.1002/cncr.33171
- By:
- Publication type:
- Article
Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.78
- By:
- Publication type:
- Article